HMGB1 and retinitis pigmentosa 1: Murakami et al. [28] investigated the vitreous of retinitis pigmentosa (RP) patients and found a significant release of extracellular HMGB-1 associated with necrotic cell death and they reported that HMGB-1 could be a new therapeutic target in RP.